An integrated analytical strategy to decipher the metabolic profile of alkaloids in Compound Kushen injection based on UHPLC-ESI-QTOF/MS^E

References

• Barbara JE, Castro-Perez JM. 2011. High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening. Rapid Commun Mass Spectrom. 25(20):3029–3040. doi: 10.1002/rcm.5197.
   PubMed Web of Science ®Google Scholar
• Bateman KP, Castro-Perez J, Wrona M, Shockcor JP, Yu K, Oballa R, Nicoll-Griffith DA. 2007. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun Mass Spectrom. 21(9):1485–1496. doi: 10.1002/rcm.2996.
   PubMed Web of Science ®Google Scholar
• Bijlsma L, Sancho JV, Hernandez F, Niessen WM. 2011. Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MSE accurate-mass spectra. J Mass Spectrom. 46(9):865–875. doi: 10.1002/jms.1963.
   PubMed Web of Science ®Google Scholar
• Bonn B, Leandersson C, Fontaine F, Zamora I. 2010. Enhanced metabolite identification with MSE and a semi-automated software for structural elucidation. Rapid Commun Mass Spectrom. 24(21):3127–3138. doi: 10.1002/rcm.4753.
   PubMed Web of Science ®Google Scholar
• Fu J, Wu H, Wu H, Deng R, Li F. 2019. Chemical and metabolic analysis of Achyranthes bidentate saponins with intestinal microflora-mediated biotransformation by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry coupled with metabolism platform. J Pharm Biomed Anal. 170:305–320. doi: 10.1016/j.jpba.2019.03.041.
   PubMed Web of Science ®Google Scholar
• Fu J, Wu H, Wu H, Deng R, Sun M. 2021. Deciphering the metabolic profile and pharmacological mechanisms of Achyranthes bidentata blume saponins using ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry coupled with network pharmacology-based investigation. J Ethnopharmacol. 274:114067. doi: 10.1016/j.jep.2021.114067.
   PubMed Web of Science ®Google Scholar
• Guo YM, Huang YX, Shen HH, Sang XX, Ma X, Zhao YL, Xiao XH. 2015. Efficacy of Compound Kushen injection in relieving cancer-related pain: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2015:840742. doi: 10.1155/2015/840742.
   PubMed Web of Science ®Google Scholar
• He R, Ou S, Chen S, Ding S. 2020. Network pharmacology-based study on the molecular biological mechanism of action for Compound Kushen injection in anti-cancer effect. Med Sci Monit. 26:e918520. doi: 10.12659/MSM.918520.
   PubMed Web of Science ®Google Scholar
• Huang MW, Li RJ, Yang M, Zhou A, Wu H, Li ZG, Wu H. 2022. Discovering the potential active ingredients of Qi-Yu-San-Long decoction for anti-oxidation, inhibition of non-small cell lung cancer based on the spectrum-effect relationship combined with chemometric methods. Front Pharmacol. 13:989139. doi: 10.3389/fphar.2022.989139.
   PubMed Web of Science ®Google Scholar
• Jiang H, Liu J, Wang Y, Chen L, Liu H, Wang Z, Wang B. 2021. Screening the Q-markers of TCMs from RA rat plasma using UHPLC-QTOF/MS technique for the comprehensive evaluation of Wu-Wei-Wen-Tong Capsule. J Mass Spectrom. 56(5):e4711. doi: 10.1002/jms.4711.
   PubMed Web of Science ®Google Scholar
• Jin Y, Yang Q, Liang L, Ding L, Liang Y, Zhang D, Wu B, Yang T, Liu H, Huang T, et al. 2018. Compound Kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway. J Exp Clin Cancer Res. 37(1):277. doi: 10.1186/s13046-018-0948-3.
   PubMed Web of Science ®Google Scholar
• Li L, Wang K, Liu Z, Lu Y, Wang C, Yi X, Guo J. 2022. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway. World J Surg Oncol. 20(1):161. doi: 10.1186/s12957-022-02609-y.
   PubMed Web of Science ®Google Scholar
• Li R, Wu H, Wang M, Zhou A, Song S, Li Q. 2022. An integrated strategy to delineate the chemical and dynamic metabolic profile of Huachansu tablets in rat plasma based on UPLC-ESI-QTOF/MSE. J Pharm Biomed Anal. 218:114866. doi: 10.1016/j.jpba.2022.114866.
   PubMed Web of Science ®Google Scholar
• Lin P, Wang Q, Liu Y, Jiang H, Lv W, Lan T, Qin Z, Yao X, Yao Z. 2021. Qualitative and quantitative analysis of the chemical profile for Gualou-Xiebai-Banxia decoction, a classical traditional Chinese medicine formula for the treatment of coronary heart disease, by UPLC-Q/TOF-MS combined with chemometric analysis. J Pharm Biomed Anal. 197:113950. doi: 10.1016/j.jpba.2021.113950.
   PubMed Web of Science ®Google Scholar
• Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang B, Zheng S. 2011. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res. 30(1):66. doi: 10.1186/1756-9966-30-66.
   PubMed Web of Science ®Google Scholar
• Nassar AE, Adams PE. 2003. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction. Curr Drug Metab. 4(4):259–271. doi: 10.2174/1389200033489406.
   PubMed Web of Science ®Google Scholar
• Pharmacopoeia Committee, Ministry of Health, PRC. 1997. Pharmaceutical standards of the ministry of health, Chinese traditional medicine formulations, volume 14, China. Beijing, China: Pharmacopoeia Committee, Ministry of Health, PRC.
   Google Scholar
• Wang KX, Du GH, Qin XM, Gao L. 2021. Compound Kushen injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating beta-catenin/c-Myc signaling. Phytomedicine. 93:153781. doi: 10.1016/j.phymed.2021.153781.
   PubMed Web of Science ®Google Scholar
• Wang R, Liu H, Shao Y, Wang K, Yin S, Qiu Y, Wu H, Liu E, Wang T, Gao X, et al. 2019. Sophoridine inhibits human colorectal cancer progression via targeting MAPKAPK2. Mol Cancer Res. 17(12):2469–2479. doi: 10.1158/1541-7786.MCR-19-0553.
   PubMed Web of Science ®Google Scholar
• Wang W, You R, Qin W, Hai L, Fang M, Huang G, Kang R, Li M, Qiao Y, Li J, et al. 2015. Anti-tumor activities of active ingredients in Compound Kushen injection. Acta Pharmacol Sin. 36(6):676–679. doi: 10.1038/aps.2015.24.
   PubMed Web of Science ®Google Scholar
• Wei R, Cao J, Yao S. 2018. Matrine promotes liver cancer cell apoptosis by inhibiting mitophagy and PINK1/Parkin pathways. Cell Stress Chaperones. 23(6):1295–1309. doi: 10.1007/s12192-018-0937-7.
   PubMed Web of Science ®Google Scholar
• Wei WL, Li HJ, Yang WZ, Qu H, Li ZW, Yao CL, Hou JJ, Wu WY, Guo DA. 2022. An integrated strategy for comprehensive characterization of metabolites and metabolic profiles of bufadienolides from Venenum bufonis in rats. J Pharm Anal. 12(1):136–144. doi: 10.1016/j.jpha.2021.02.003.
   PubMed Web of Science ®Google Scholar
• Wu C, Huang ZH, Meng ZQ, Fan XT, Lu S, Tan YY, You LM, Huang JQ, Stalin A, Ye PZ, et al. 2021. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of Compound Kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation. Chin Med. 16(1):121. doi: 10.1186/s13020-021-00534-y.
   PubMed Web of Science ®Google Scholar
• Wu H, Chen Y, Li Z, Liu X. 2018. Untargeted metabolomics profiles delineate metabolic alterations in mouse plasma during lung carcinoma development using UPLC-QTOF/MS in MSE mode. R Soc Open Sci. 5(9):181143. doi: 10.1098/rsos.181143.
   PubMed Web of Science ®Google Scholar
• Wu H, Cheng H, Luo SY, Peng C, Zhou A, Chen ZW, Wu H, Li QL. 2022. Use of cellular metabolomics and lipidomics to decipher the mechanism of Huachansu injection-based intervention against human hepatocellular carcinoma cells. J Pharm Biomed Anal. 212:114654. doi: 10.1016/j.jpba.2022.114654.
   PubMed Web of Science ®Google Scholar
• Wu H, Li XX, Yan XM, An L, Luo KW, Shao MJ, Jiang Y, Xie R, Feng F. 2015. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma. J Pharm Biomed Anal. 115:315–322. doi: 10.1016/j.jpba.2015.07.026.
   PubMed Web of Science ®Google Scholar
• Wu H, Wang LN, Zhan X, Wang B, Wu JW, Zhou A. 2020. A UPLC-Q-TOF/MS-based plasma metabolomics approach reveals the mechanism of Compound Kushen injection-based intervention against non-small cell lung cancer in Lewis tumor-bearing mice. Phytomedicine. 76:153259. doi: 10.1016/j.phymed.2020.153259.
   PubMed Web of Science ®Google Scholar
• Yu JS, Nothias LF, Wang M, Kim DH, Dorrestein PC, Kang KB, Yoo HH. 2022. Tandem mass spectrometry molecular networking as a powerful and efficient tool for drug metabolism studies. Anal Chem. 94(2):1456–1464. doi: 10.1021/acs.analchem.1c04925.
   PubMed Web of Science ®Google Scholar
• Yu L, Zhou Y, Yang Y, Lu F, Fan Y. 2017. Efficacy and safety of Compound Kushen injection on patients with advanced colon cancer: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2017:7102514. doi: 10.1155/2017/7102514.
   PubMed Web of Science ®Google Scholar
• Yu ZY, Peng RY, Han M, Grant S, Yang GY, Liu JP, Cao HJ. 2021. Adjunctive effect of Compound Kushen injection to chemotherapy for non-small cell lung cancer: an evidence map and overview of systematic reviews. J Ethnopharmacol. 281:114538. doi: 10.1016/j.jep.2021.114538.
   PubMed Web of Science ®Google Scholar
• Zhan X, Wu H, Wu H. 2020. Joint synovial fluid metabolomics method to decipher the metabolic mechanisms of adjuvant arthritis and geniposide intervention. J Proteome Res. 19(9):3769–3778. doi: 10.1021/acs.jproteome.0c00300.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li C, Fu C, Dong J, Guo W, Zhu Q. 2021. Effect of psychological intervention combined with family cooperation on the perioperative quality of life and psychological states of elderly patients with prostate cancer treated with Compound Kushen injection. Evid Based Complement Alternat Med. 2021:2971644. doi: 10.1155/2021/2971644.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen Y, Li RJ, Zheng T, Huang MW, Gao YT, Li ZG, Wu H. 2023. An ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry method based on a four-step analysis strategy to investigate metabolites of Qi-Yu-San-Long decoction in rat plasma. Rapid Commun Mass Spectrom. 37(1):e9419. doi: 10.1002/rcm.9419.
   PubMed Web of Science ®Google Scholar
• Zheng T, Zhao Y, Li RJ, Huang MW, Zhou A, Li ZG, Wu H. 2022. The dynamic metabolic profile of Qi-Yu-San-Long decoction in rat urine using UPLC-QTOF-MSE coupled with a post-targeted screening strategy. J Pharm Anal. 12(5):755–765. doi: 10.1016/j.jpha.2022.05.005.
   PubMed Web of Science ®Google Scholar
• Zhou W, Huang Z, Wu C, Lu S, Fu C, Ye P, Tan Y, Wu Z, Fan X, Zhang J, et al. 2021. Investigation on the clinical efficacy and mechanism of Compound Kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment. J Ethnopharmacol. 279:114386. doi: 10.1016/j.jep.2021.114386.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zhu Y, Tao S, Liang W, Zhang J, Zhang Y, Xuan Z, Xu J, Peng C, Wu H, et al. 2022. The integrated study on the chemical profiling to explore the constituents and mechanism of traditional Chinese medicine preparation Huatuo Jiuxin pills based on UPLC-Q-TOF/MSE and network pharmacology. Front Mol Biosci. 9:818285. doi: 10.3389/fmolb.2022.818285.
   PubMed Web of Science ®Google Scholar